STA
MEDP icon

Summit Trail Advisors’s Medpace MEDP Stock Holding History

Summit Trail Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
2,605
-44
-2% -$20.3K 0.02% 840
2026
Q1 		$1.27M Buy
2,649
+992
+60% +$508K 0.02% 817
2025
Q4 		$931K Buy
1,657
+792
+92% +$450K 0.02% 851
2025
Q3 		$445K Buy
+865
New +$378K 0.01% 1111

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Summit Trail Advisors's MEDP Position: Q2 2026 in Review

Summit Trail Advisors reduced its Medpace (MEDP) stake by 1.7% in Q2 2026, selling an estimated $20.3K and leaving 2,605 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #840.

Summit Trail Advisors first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Summit Trail Advisors held 2,605 shares of Medpace worth $1.38M as of Q2 2026.
  • Summit Trail Advisors sold 44 Medpace shares in Q2 2026, an estimated $20.3K.
  • Medpace made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #840 holding.
  • Summit Trail Advisors first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.